Replies to post #662 on Trillium Therapeutics Inc (TRIL)

[Inoviorulez]

Trillium TRIL has the technology to do it. This is going to be the top 2020 play in biotechs. They got 3 anti-CD47 products along with a second-generation sting agonist that can be given both oral or intravenously. Plus an immuno-oncology product in preclinical testing.